SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-19-000090
Filing Date
2019-11-12
Accepted
2019-11-12 08:17:39
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare_10qx20190930.htm 10-Q 846146
2 EXHIBIT 10.1 dare-employeeperformancebo.htm EX-10.1 19312
3 EXHIBIT 31.1 exhibit311_20190930.htm EX-31.1 18328
4 EXHIBIT 31.2 exhibit312_20190930.htm EX-31.2 17657
5 EXHIBIT 32.1 exhibit321_20190930.htm EX-32.1 4948
6 EXHIBIT 32.2 exhibit322_20190930.htm EX-32.2 5035
13 darebioinlinefullcolorrgb.jpg GRAPHIC 130914
  Complete submission text file 0001401914-19-000090.txt   4191462

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dare-20190930.xml EX-101.INS 548169
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20190930.xsd EX-101.SCH 49071
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20190930_cal.xml EX-101.CAL 45468
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20190930_def.xml EX-101.DEF 196962
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20190930_lab.xml EX-101.LAB 543489
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20190930_pre.xml EX-101.PRE 298014
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 191206307
SIC: 2834 Pharmaceutical Preparations